Logo

Study reveals new indicators for HER2+ breast cancer response to therapy

Study reveals new indicators for HER2+ breast cancer response to therapy

Envision this possible future clinical scenario: a breast cancer patient and her physicians are deciding on the best possible treatment. Their decision is informed by a comprehensive molecular profile of the patient's cancer samples that predicts the most likely response of the cancer to treatment.

👉 Full Story